{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T09:14:16Z","timestamp":1770974056761,"version":"3.50.1"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.micpath.2015.11.018","type":"journal-article","created":{"date-parts":[[2015,11,25]],"date-time":"2015-11-25T16:58:56Z","timestamp":1448470736000},"page":"72-75","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Correlation between clinical symptoms and peripheral immune response in HAM\/TSP"],"prefix":"10.1016","volume":"92","author":[{"given":"George Alberto","family":"da Silva Dias","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita Catarina Medeiros","family":"Sousa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Let\u00edcia Figueiredo","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cezar Augusto Muniz","family":"Caldas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reza","family":"Nassiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juarez Ant\u00f4nio Sim\u00f5es","family":"Quaresma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hellen Thais","family":"Fuzii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.micpath.2015.11.018_bib1","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.virusres.2011.08.014","article-title":"Detection of human T-cell lymphotropic virus type 1 in plasma samples","volume":"163","author":"Cabral","year":"2012","journal-title":"Virus Res."},{"key":"10.1016\/j.micpath.2015.11.018_bib2","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.coviro.2012.06.007","article-title":"Mechanisms of human T-lymphotropic virus type 1 transmission and disease","volume":"2","author":"Lairmore","year":"2012","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.micpath.2015.11.018_bib3","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s11481-010-9216-9","article-title":"Neuroimmunity of HTLV-I infection","volume":"5","author":"Matsuura","year":"2010","journal-title":"J.\u00a0Neuroimmune Pharmacol."},{"key":"10.1016\/j.micpath.2015.11.018_bib4","doi-asserted-by":"crossref","first-page":"222","DOI":"10.4161\/viru.19697","article-title":"Blood-brain barrier and retroviral infections","volume":"3","author":"Miller","year":"2012","journal-title":"Virulence"},{"key":"10.1016\/j.micpath.2015.11.018_bib5","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/s12185-011-0934-4","article-title":"Current status of HTLV-1 infection","volume":"94","author":"Watanabe","year":"2011","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.micpath.2015.11.018_bib6","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1590\/S0104-42302010000300021","article-title":"Human T-cell lymphotropic virus type 1 (HTLV-1): when to suspect infection?","volume":"56","author":"Romanelli","year":"2010","journal-title":"Rev. Assoc. Med. Bras."},{"key":"10.1016\/j.micpath.2015.11.018_bib7","first-page":"8461","article-title":"Immunogenetics and the pathological mechanisms of human T-cell leukemia virus type 1- (HTLV-1-) associated myelopathy\/tropical spastic paraparesis (HAM\/TSP)","volume":"47","author":"Saito","year":"2010","journal-title":"Interdiscip. Perspect. Infect. Dis."},{"key":"10.1016\/j.micpath.2015.11.018_bib8","doi-asserted-by":"crossref","first-page":"98","DOI":"10.2174\/187152808785107642","article-title":"HTLV-1-Associated Myelopathy\/Tropical spastic paraparesis (HAM\/TSP) inflammatory Network","volume":"7","author":"Gon\u00e7alves","year":"2008","journal-title":"Inflamm. Allergy Drug. Targets"},{"key":"10.1016\/j.micpath.2015.11.018_bib9","doi-asserted-by":"crossref","first-page":"e2251","DOI":"10.1371\/journal.pone.0002251","article-title":"Human T-lymphotropic virus-1 visualized at the virological synapse by electron tomography","volume":"3","author":"Majorovits","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.micpath.2015.11.018_bib10","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.cytogfr.2011.08.002","article-title":"Modulation of innate immune responses during human T-cell leukemia virus (HTLV-1) pathogenesis","volume":"22","author":"Oli\u00e9re","year":"2011","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.micpath.2015.11.018_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3960\/jslrt.50.1","article-title":"HTLV-1 and the host immune system: how the virus disrupts immune regulation, leading to HTLV-1 associated diseases","volume":"50","author":"Satou","year":"2010","journal-title":"J.\u00a0Clin. Exp. Hematop"},{"key":"10.1016\/j.micpath.2015.11.018_bib12","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1002\/jmv.22087","article-title":"Human T cell lymphotropic virus type 1 (HTLV-1) proviral load of HTLV-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP) patients according to new diagnostic criteria of HAM\/TSP","volume":"83","author":"Grassi","year":"2011","journal-title":"J.\u00a0Med. Virol."},{"key":"10.1016\/j.micpath.2015.11.018_bib13","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.3390\/v3081374","article-title":"HTLV-1 and innate immunity","volume":"3","author":"Journo","year":"2011","journal-title":"Viruses"},{"key":"10.1016\/j.micpath.2015.11.018_bib14","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3389\/fmicb.2012.00389","article-title":"Clinical pathophysiology of human T-lymphotropic virus-type 1-associated myelopathy\/tropical spastic paraparesis","volume":"3","author":"Yamano","year":"2012","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.micpath.2015.11.018_bib15","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/S1474-4422(06)70628-7","article-title":"The HTLV-1 neurological complex","volume":"5","author":"Araujo","year":"2006","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.micpath.2015.11.018_bib16","doi-asserted-by":"crossref","first-page":"e777","DOI":"10.1111\/j.1365-2567.2009.03082.x","article-title":"IFN-gamma production in response to Tax 161-223, and frequency of CD4+Foxp3+ and Lin HLA Rhigh CD123+ cells, discriminate HAM\/TSP patients from asymptomatic HTLV-1-carriers in a Peruvian population","volume":"128","author":"Best","year":"2009","journal-title":"Immunology"},{"key":"10.1016\/j.micpath.2015.11.018_bib17","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1212\/WNL.0b013e3181b6bba9","article-title":"Neurologic abnormalities in HTLV-I\u2013 and HTLV-II\u2013infected individuals without overt myelopathy","volume":"73","author":"Biswas","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.micpath.2015.11.018_bib18","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1136\/jnnp.2008.167155","article-title":"The neurology of HTLV-1 infection","volume":"9","author":"Cooper","year":"2009","journal-title":"Pract. Neurol."},{"key":"10.1016\/j.micpath.2015.11.018_bib19","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.biopha.2007.02.006","article-title":"Induction of pro-inflammatory cytokines by human T-cell leukemia virus type-1 Tax protein as determined by multiplexed cytokine protein array analyses of human dendritic cells","volume":"61","author":"Ahuja","year":"2007","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.micpath.2015.11.018_bib20","doi-asserted-by":"crossref","first-page":"5047","DOI":"10.1182\/blood-2007-10-118539","article-title":"High frequency of CD4+FoxP3+ cells in HTLV-1 infection: inverse correlation with HTLV-1-especific CTL response","volume":"111","author":"Toulza","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.micpath.2015.11.018_bib21","doi-asserted-by":"crossref","first-page":"e6517","DOI":"10.1371\/journal.pone.0006517","article-title":"Abnormally high levels of virus-infected INF-gamma+CCR4+CD4+CD25+ T cells in a retrovirus-associated neuroinflammatory disorder","volume":"4","author":"Yamano","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.micpath.2015.11.018_bib22","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1365-2249.2006.03252.x","article-title":"IL-10 produced by CD4+ and CD8+ T cells emerge as a putative immunoregulatory mechanism to counterbalance the monocyte-derived TNF-alpha and guarantee asymptomatic clinical status during chronic HTLV-I infection","volume":"147","author":"Brito-Melo","year":"2007","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.micpath.2015.11.018_bib23","first-page":"11","article-title":"Imunopatog\u00eanese da mielopatia associada ao HTLV-I","volume":"79","author":"Santos","year":"2009","journal-title":"Gaz. M\u00e9d. Bahia"},{"key":"10.1016\/j.micpath.2015.11.018_bib24","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/j.1440-1789.2010.01135.x","article-title":"Neuropathology of HTLV-1-associated myelopathy (HAM\/TSP)","volume":"30","author":"Izumo","year":"2010","journal-title":"Neuropathology"},{"key":"10.1016\/j.micpath.2015.11.018_bib25","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.autneu.2009.05.252","article-title":"Evaluation of autonomic malfunction in HTLV-1 associated myelopathy (HAM)","volume":"150","author":"Kuriyama","year":"2009","journal-title":"Auton. Neurosci."},{"key":"10.1016\/j.micpath.2015.11.018_bib26","first-page":"505","article-title":"HTLV-1 associated myelopathy\/tropical spastic paraparesis: how far have we come?","volume":"60","author":"Morgan","year":"2011","journal-title":"West Indian Med. J."},{"key":"10.1016\/j.micpath.2015.11.018_bib27","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1080\/13550280390194028","article-title":"Human T-cell lymphotropic virus type I and neurological diseases","volume":"9","author":"Nagai","year":"2003","journal-title":"J.\u00a0Neurovirol"},{"key":"10.1016\/j.micpath.2015.11.018_bib28","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1590\/S0004-282X2012000400004","article-title":"HAM\/TSP: association between white matter lesions on magnetic resonance imaging, clinical and cerebrospinal fluid findings","volume":"70","author":"Puccioni-Sohler","year":"2012","journal-title":"Arq. Neuropsiquiatr."},{"key":"10.1016\/j.micpath.2015.11.018_bib29","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1590\/S0004-282X2009000500016","article-title":"Pain in tropical spastic paraparesis\/HTLV-I associated myelopathy patients","volume":"67","author":"Castro-Costa","year":"2009","journal-title":"Arq. Neuropsiquiatr."},{"key":"10.1016\/j.micpath.2015.11.018_bib30","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jcv.2011.02.004","article-title":"Clinical manifestations in individuals with recent diagnosis of HTLV type I infection","volume":"51","author":"Poetker","year":"2011","journal-title":"J.\u00a0Clin. Virol."},{"key":"10.1016\/j.micpath.2015.11.018_bib31","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1089\/aid.2006.22.931","article-title":"Proposal for diagnostic criteria of tropical spastic paraparesis\/HTLV-I-associated myelopathy (TSP\/HAM)","volume":"22","author":"Castro-Costa","year":"2006","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.micpath.2015.11.018_bib32","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/ptj\/67.2.206","article-title":"Interrater reliability of a modified Ashworth scale of muscle spasticity","volume":"67","author":"Bohannon","year":"1987","journal-title":"Phys. Ther."},{"key":"10.1016\/j.micpath.2015.11.018_bib33","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1677\/jme.1.01755","article-title":"Quantitative real-time RT-PCR\u2013a perspective","volume":"34","author":"Bustin","year":"2005","journal-title":"J.\u00a0Mol. Endocrinol."},{"key":"10.1016\/j.micpath.2015.11.018_bib34","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2002-3-7-research0034","article-title":"Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes","volume":"3","author":"Vandesompele","year":"2002","journal-title":"Genome Biol."},{"key":"10.1016\/j.micpath.2015.11.018_bib35","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.3390\/v3091532","article-title":"Human T-lymphotropic virus type 1 (HTLV-1) and regulatory T cells in HTLV-1-associated neuroinflammatory disease","volume":"3","author":"Araya","year":"2011","journal-title":"Viruses"},{"key":"10.1016\/j.micpath.2015.11.018_bib36","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1128\/CMR.00063-09","article-title":"Epidemiology, treatment, and prevention of human T-cell leukemia virus type 1-associated diseases","volume":"23","author":"Gon\u00e7alves","year":"2010","journal-title":"Clin. Microbiol. Ver."},{"key":"10.1016\/j.micpath.2015.11.018_bib37","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1365-3083.2009.02291.x","article-title":"The elevated interferon gamma production is an important immunological marker in HAM\/TSP pathogenesis","volume":"70","author":"Montanheiro","year":"2009","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.micpath.2015.11.018_bib38","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1590\/S0004-282X2006000200009","article-title":"Association of cytokines, neurological disability, and disease duration in HAM\/TSP patients","volume":"64","author":"Muniz","year":"2006","journal-title":"Arq. Neuropsiquiatr."},{"key":"10.1016\/j.micpath.2015.11.018_bib39","first-page":"182","article-title":"HTLV-I-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP): the role of HTLV-I-infected Th1 cells in the pathogenesis, and therapeutic strategy","volume":"47","author":"Nakamura","year":"2009","journal-title":"Folia Neuropathol."},{"key":"10.1016\/j.micpath.2015.11.018_bib40","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1620\/tjem.204.289","article-title":"Increased mRNA expression of Th1-cytokine signaling molecules in patients with HTLV-I-associated myelopathy\/tropical spastic paraparesis","volume":"204","author":"Nishiura","year":"2004","journal-title":"Tohoku J. Exp. Med."},{"key":"10.1016\/j.micpath.2015.11.018_bib41","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000097259","article-title":"Modulation of T cell responses in HTLV-1 carriers and in patients with myelopathy associated with HTLV-1","volume":"13","author":"Santos","year":"2006","journal-title":"Neuroimmunomodulation"}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088240101530142X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088240101530142X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T17:52:33Z","timestamp":1718214753000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S088240101530142X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":41,"alternative-id":["S088240101530142X"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2015.11.018","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correlation between clinical symptoms and peripheral immune response in HAM\/TSP","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2015.11.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}